INVITRO INDUCTION OF PRIMARY CTL RESPONSE AGAINST WILD-TYPE OR MUTANT P53 PEPTIDES

被引：0
|
作者：
HOUBIERS, JGA
NIJMAN, HW
VANDERBURG, SH
DRIJFHOUT, JW
KENEMANS, P
VANDERVELDE, CHJ
BRAND, A
KAST, WM
MELIEF, CJM
机构：
[1] LEIDEN UNIV HOSP,DEPT IMMUNOHAEMATOL & BLOOD BANK,2333 AA LEIDEN,NETHERLANDS
[2] LEIDEN UNIV HOSP,DEPT SURG,2333 AA LEIDEN,NETHERLANDS
[3] FREE UNIV AMSTERDAM HOSP,DEPT OBSTET & GYNECOL,AMSTERDAM,NETHERLANDS
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [41] Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation
    De Smet, Frederik
    Rubio, Mirian Saiz
    Hompes, Daphne
    Naus, Evelyne
    De Baets, Greet
    Langenberg, Tobias
    Hipp, Mark S.
    Houben, Bert
    Claes, Filip
    Charbonneau, Sarah
    Blanco, Javier Delgado
    Plaisance, Stephane
    Ramkissoon, Shakti
    Ramkissoon, Lori
    Simons, Colinda
    van den Brandt, Piet
    Weijenberg, Matty
    Van England, Manon
    Lambrechts, Sandrina
    Amant, Frederic
    D'Hoore, Andre
    Ligon, Keith L.
    Sagaert, Xavier
    Schymkowitz, Joost
    Rousseau, Frederic
    JOURNAL OF PATHOLOGY, 2017, 242 (01): : 24 - 38
  • [42] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    A Vinyals
    M A Peinado
    M Gonzalez-Garrigues
    M Monzó
    R D Bonfil
    A Fabra
    Gene Therapy, 1999, 6 : 22 - 33
  • [43] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    Vinyals, A
    Peinado, MA
    Gonzalez-Garrigues, M
    Monzó, M
    Bonfil, RD
    Fabra, A
    GENE THERAPY, 1999, 6 (01) : 22 - 33
  • [44] WILD-TYPE P53 INDUCED APOPTOSIS IN A BURKITT-LYMPHOMA (BL) LINE THAT CARRIES MUTANT P53
    RAMQVIST, T
    MAGNUSSON, KP
    WANG, YS
    SZEKELY, L
    KLEIN, G
    WIMAN, KG
    ONCOGENE, 1993, 8 (06) : 1495 - 1500
  • [45] The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
    Gobert, C
    Skladanowski, A
    Larsen, AK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10355 - 10360
  • [46] The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
    Li, Dan-Dan
    Sun, Ting
    Wu, Xiao-Qi
    Chen, Shu-Peng
    Deng, Rong
    Jiang, Shan
    Feng, Gong-Kan
    Pan, Jing-Xuan
    Zhang, Xiao-Shi
    Zeng, Yi-Xin
    Zhu, Xiao-Feng
    PLOS ONE, 2012, 7 (09):
  • [47] Contribution of the p53 pathway in cancers that carry wild-type p53
    Ohki, Rieko
    CANCER SCIENCE, 2022, 113 : 1232 - 1232
  • [48] Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
    Gnjatic, S
    Cai, ZZ
    Viguier, M
    Chouaib, S
    Guillet, JG
    Choppin, J
    JOURNAL OF IMMUNOLOGY, 1998, 160 (01): : 328 - 333
  • [49] Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
    Kaypee, Stephanie
    Sahadevan, Smitha Asoka
    Patil, Shilpa
    Ghosh, Piya
    Roy, Neeladri Sekhar
    Roy, Siddhartha
    Kundu, Tapas K.
    ISCIENCE, 2018, 4 : 260 - +
  • [50] Wild-type and mutant p53 proteins interact with mitochondrial caspase-3
    Frank, Amanda K.
    Pietsch, E. Christine
    Dumont, Patrick
    Tao, Joy
    Murphy, Maureen E.
    CANCER BIOLOGY & THERAPY, 2011, 11 (08) : 740 - 745
12345